Stryker Corporation
SYK Healthcare Medical Devices
Stryker Corporation’s revenue for fiscal 2025 (year ended December 2025) was $25.1 billion, up 11.2% from fiscal 2024. In the quarter to June 2026, revenue grew 9.42%, EPS grew 43.1%, free cash flow grew 14.1% and total debt fell 9.88%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for five, operating cash flow growth for three.
Follow SYK
Stryker Corporation (SYK) Operating cash flow
Stryker Corporation's operating cash flow for fiscal 2025 was $5.0B, up 18.9% from $4.2B in fiscal 2024. Over the twelve months to 30 June 2026 it was $5.5B. Over the past ten years it has ranged from $981.0M (fiscal 2015) to $5.0B (fiscal 2025) — the current reading is the highest in ten years. Operating cash flow has risen for 3 consecutive fiscal years. Stryker Corporation ranks 3rd of 149 Medical Devices companies by operating cash flow.
Operating cash flow, annual
Embed this chart
Annual newest first
| Period | Operating cash flow | Change |
|---|---|---|
| FY2025 | $5.0B | 18.91% |
| FY2024 | $4.2B | 14.31% |
| FY2023 | $3.7B | 41.43% |
| FY2022 | $2.6B | (19.58%) |
| FY2021 | $3.3B | (0.43%) |
| FY2020 | $3.3B | 49.57% |
| FY2019 | $2.2B | (16.05%) |
| FY2018 | $2.6B | 67.42% |
| FY2017 | $1.6B | (18.59%) |
| FY2016 | $1.9B | 95.21% |
Quarterly newest first
| Period | Operating cash flow | Change |
|---|---|---|
| Jun 2026 | $1.3B | 117.04% |
| Mar 2026 | $581.0M | (72.89%) |
| Dec 2025 | $2.1B | 39.16% |
| Sep 2025 | $1.5B | 38.61% |
| 42 more quarters | Free account |
Against its own ten years
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| ABT Abbott Laboratories compare | $9.9B |
| MDT Medtronic PLC compare | $8.0B |
| SYK Stryker Corporation | $5.5B |
| BSX Boston Scientific Corporation compare | $4.5B |
| PHG Koninklijke Philips N.V. compare | $2.6B |
| GEHC GE HealthCare Technologies Inc. compare | $2.1B |
| DXCM DexCom, Inc. compare | $1.7B |
| EW Edwards Lifesciences Corporation compare | $1.7B |
| STE STERIS plc compare | $1.3B |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item
More on SYK
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement